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SalmoneUla choleraesuis (a pig pathogen), SalnoneUla typhimurium (a virulent strain in mice), and three
strains ofEscherichia coli (including a human enterohemorrhagic strain, a human urinary tract isolate, and a
human fecal isolate) grew as well in vitro utilizing the lipids derived from mouse cecal mucus as the sole source
of carbon and nitrogen as they did in mouse crude cecal mucus. Further analysis of the total lipid extracts of
mucus dialysates showed that the acidic lipid fraction supported growth nearly as weli as the total lipid fraction.
Interestingly, among the many purified acidic lipids from mucus which were tested and analyzed, including
several phospholipids, only phosphatidylserine was found to support the growth of all of these enteric bacteria,
including Sabnonela milwaukee, a human pathogen. The possible role of growth on pure phosphatidylserine in
the pathogenesis of salmonellae is discussed.
The mucus gel of the gastrointestinal tracts of humans and
animals has been suggested to function as an important
barrier to bacterial infection and invasion by entrapping
enteric pathogens and inhibiting their attachment to the
underlying mucosal cell surface (2). The mucus gel has also
been suggested to serve as an important substrate for com-
mensal mucin-degrading bacteria (11, 18) and as colonization
sites for other enteric bacteria (6, 7, 13, 16). Mucus occurs as
a viscous, sticky, water-insoluble gel which is composed of
a high-molecular-weight glycoprotein (mucin) and smaller
proteins and glycoproteins, although it is now known that
many lipids are also associated noncovalently with the gel
layer (17, 21). It has recently been shown that for Esche-
richia coli and Salmonella typhimurium to colonize the
colons of streptomycin-treated mice, they must be able to
grow in the mucus layer (12, 20). The data that we present
here indicate that several serovars of Salmonella and E. coli
are able to utilize lipids existing in the mucus layer for
growth, of which phosphatidylserine was found to serve as
the sole source of both carbon and nitrogen for growth for all
of these enteric bacteria.
Dialysates of male CD-1 mouse cecal mucus, which sup-
port growth of E. coli and S. typhimurium as well as crude
cecal mucus does in vitro (8), were used as the source of
cecal mucus lipids. Lipids were extracted from mucus dialy-
sates in chloroform-methanol-water (4:8:3) (19) or in chloro-
form-methanol (2:1) (17) and separated into neutral and
acidic fractions by high-performance liquid chromatography
(HPLC) on silica Iatrobeads (1) and by anion-exchange
chromatography on DEAE-cellulose, respectively (15).
Each lipid fraction was dried under nitrogen and dispersed
by sonication into HEPES (N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid)-Hanks buffer, pH 7.4, at 1 mg/ml, and
the samples were inoculated with about 2 x 104 CFU of
bacteria per ml. As shown in Table 1, S. typhimurium
SL7312, a virulent strain, and E. coli F-18, a normal human
* Corresponding author.
fecal strain (4), grew essentially as well utilizing cecal mucus
total lipids as the sole source of carbon and nitrogen as in the
cecal mucus dialysate itself for the first 6 h of incubation at
37°C. Moreover, in the presence of total cecal mucus lipids,
levels (CFU per milliliter) of about 20% of that reached in
cecal mucus dialysates at 24 h were observed (Table 1). The
cecal mucus acidic lipids were also effective in promoting
growth, whereas the neutral lipid fraction was relatively
ineffective (Table 1). Interestingly, the pattern of growth of
Salmonella choleraesuis 735B, a pig pathogen, was identical
to that of S. typhimurium in cecal mucus total lipids and
acidic lipids (data not shown), and E. coli 933 EDL (0157:
H7), a human enterohemorrhagic strain, and E. coli A55 (06,
Pap' Hly+), a pathogen causing human urinary tract infec-
tions, grew in the total and acidic fractions essentially
identically to E. coli F-18 (data not shown).
Gangliosides, sulfatides, and phospholipids make up the
majority of acidic lipids of mammalian cells, whereas the
majority of neutral lipids are glycosphingolipids (10). There-
fore, several phospholipids (phosphatidylcholine, phos-
phatidylethanolamine, phosphatidylinositol, phosphatidyl-
serine, and sphingomyelin [Avanti Polar Lipids, Inc.,
Alabaster, Ala.]), purified mixtures of standard monosialo-
gangliosides (GM1, GM2, and GM3 [BioCarb Chemicals,
Lund, Sweden]), disialogangliosides (GD1a, GDlb, GD2, and
GD3 [BioCarb Chemicals]), and a standard mixture of neu-
tral glycosphingolipids which contained galactosylceramide,
lactosylceramide, globotriaosylceramide, globoside, and
Forssman glycolipid (BioCarb Chemicals) were tested for
their ability to support the growth of E. coli and salmonellae.
Neither the E. coli nor the Salmonella strains grew to any
great extent on the mixtures of known standard gangliosides
or neutral glycosphingolipids (Table 2). Of the purified
phospholipids used as the sole source of carbon and nitro-
gen, only phosphatidylserine supported growth of S. typhi-
murium SL7312 and E. coli F-18 to any great extent (Table
3). The other phospholipids were unable to support the
growth of these bacteria. Similarly, phosphatidic acid, a
combination of phosphatidic acid and L-serine, L-serine
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TABLE 1. Growth of S. typhimurium SL7312 and E. coli F-18 on
cecal mucus lipids as the sole source of carbon and nitrogen
CFU relative to input CFU' at:
Substrate 6 h 24 h
F-18 SL7312 F-18 SL7312
Dialysate 264 1,506 6,436 12,875
Total lipids' 620 916 1,551 2,125
Acidic lipids 158 416 437 625
Neutral lipids 0.14 1.83 0.02 4.44
HHC 0.55 0.85 2.53 6.55
a Input CFU per milliliter: E. coli F-18, 8.1 x 104; S. typhimurium SL7312,
6.6 x 104.
b Lipids were dispersed in HEPES-Hanks buffer, pH 7.4, at a concentration
of 1 mg/ml.
c HEPES-Hanks buffer, pH 7.4.
alone, and O-phospho-L-serine (Sigma Chemical Co., St.
Louis, Mo.) did not support growth, although L-serine and
O-phospho-L-serine did allow low levels of growth by 24 h
(Table 3). Together, the data suggest that phosphatidylserine
itself is transported and then metabolized. The human en-
terohemorrhagic E. coli and urinary tract infection-causing
strains also utilized phosphatidylserine for growth to the
same extent as E. coli F-18 (data not shown), and S.
choleraesuis 735B utilized phosphatidylserine to the same
extent as S. typhimurium SL7312 (Table 4). Similarly, S.
milwaukee, a human pathogen, utilized phosphatidylserine
for growth as efficiently as the other Salmonella strains (data
not shown). Phosphatidylserine obtained from Sigma Chem-
ical Co. (bovine brain, 98% pure) or from Avanti Polar
Lipids (bovine brain, >99% pure) supported growth of the
Salmonella and E. coli strains in a similar fashion (data not
shown).
To determine the amount of phosphatidylserine present in
mouse cecal mucus, the acidic lipid fraction was hydrolyzed
with 6 N HCl for 18 h at 120°C, and released serine was
measured by the PICO-TAG method with phenyl isothiocy-
anate (5). Derivatized serine was separated and quantified by
reverse-phase HPLC with a Supelcosil LC-18 column (3). As
shown in Fig. 1, the HPLC profile obtained from the acidic
lipid fraction (Fig. lb) included a peak with a retention value
identical to that of the authentic phosphatidylserine standard
(Fig. la). Comparative analysis of the integrated peak areas
indicated that 33.5 ,ug of phosphatidylserine per mg of total
TABLE 2. Growth of E. coli F-18 and S. typhimunum SL7312
on a mixture of standard acidic glycosphingolipids
(gangliosides) and neutral glycosphingolipids
CFU relative to input CFUa at:
Substrate 6 h 24 h
F-18 SL7312 F-18 SL7312
Monosialogangliosides" 0.69 0.89 0.10 3.25
Disialogangliosides 0.75 1.52 0.02 5.45
Neutral glycosphingolipids 0.92 1.39 <0.02 5.16
HHC 0.85 0.81 0.21 1.69
a Input CFU per milliliter: E. coli F-18, 5.2 x 104; S. typhimurium SL7312,
6.4 x 104, where data are presented as the ratios of CFU at 6 and 24 h to the
input CFU.
"Mixtures of purified standards were dispersed in HEPES-Hanks buffer,
pH 7.4, at a concentration of 1 mg/ml.
c HEPES-Hanks buffer, pH 7.4.
TABLE 3. Growth of S. typhimurium SL7312 and E. coli F-18
on selected purified phospholipids
CFU relative to input CFU" at:
Substratea 6 h 24 h
F-18 SL7312 F-18 SL7312
Phosphatidylserine 6.78 21.91 203 1,319
Phosphatidylcholine 1.70 1.10 6.65 3.47
Phosphatidylethanolamine 0.74 0.49 0.52 0.70
Phosphatidylinositol 1.60 0.66 0.91 0.51
Sphingomyelin 0.65 0.36 0.30 0.12
Phosphatidic acid + L-serine 1.26 0.55 0.52 0.19
Choline chloride 3.42 2.44 2.63 4.71
L-Serine 1.62 1.71 21.53 36.06
O-PhosphO-L-serine 2.41 3.62 31.13 36.52
HHC 1.39 0.78 0.74 0.45
a Unless otherwise noted, all substrates were suspended in HEPES-Hanks
buffer, pH 7.4, at 1 mg/mi.
" Input CFU per milliliter: E. coli F-18, 2.3 x 104; S. typhimurium SL7312,
4.7 x 104.
c HEPES-Hanks buffer, pH 7.4.
lipid extracted from mouse cecal mucus was present. In
addition, cecal mucus dialysate, total lipids, and phospha-
tidylserine were treated with phospholipase A2 (Sigma
Chemical Co.) to cleave the fatty acid from the 2 position
of the phospholipids and with phospholipase D (Sigma
Chemical Co.) to hydrolyze the two fatty acids from each
phospholipid. The enzyme-treated samples were dialyzed
against water, and each enzyme-free dialysate was lyophi-
lized, resuspended in water to its original volume, and
inoculated at about 5 x 104 CFU/ml with either S. typhimu-
rium SL7312 or E. coli F-18. As shown in Table 5, the
enzyme-treated samples did not support growth nearly as
well as the untreated samples. Therefore, these data fur-
ther support the view that phospholipids, and more speci-
fically, phosphatidylserine, are primarily responsible for
Salmonella and E. coli growth in mouse cecal mucus dialy-
sates.
E. coli and salmonellae are known to utilize long-chain
fatty acids as the sole source of carbon after a long lag period
(14) and to use L-serine as the sole source of carbon and
nitrogen (9). To our knowledge, however, nothing regarding
the ability of salmonellae and E. coli to utilize lipids as the
sole source of carbon and nitrogen is known. In the present
study, we have focused on those lipids present in cecal
TABLE 4. Growth of S. typhimurium SL7312 and
S. choleraesuis 735B on selected purified phospholipids
CFU relative to input CFU" at:
Subgtratea 6 h 24 h
SL7312 735B SL7312 735B
Phosphatidylserine 29.18 28.10 222 533
Phosphatidylcholine 2.06 5.48 3.10 5.28
Phosphatidylethanolamine 0.43 0.81 1.42 1.95
Phosphatidylinositol 0.43 1.24 0.80 3.38
Phosphatidic acid 0.20 1.38 1.04 2.33
HHC 0.37 1.48 0.88 2.48
a Phospholipids were dispersed in HEPES-Hanks buffer, pH 7.4, at a
concentration of 1 mg/ml.
b Input CFU per milliliter: S. typhimurium SL7312, 4.9 x 104; S. choler-
aesuis 735B, 2.1 x 104.
c HEPES-Hanks buffer, pH 7.4.
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FIG. 1. Results of HPLC of serine hydrolytically released from
phosphatidylserine. Standard phosphatidylserine (1p,g) (a) and the
acidic lipid fraction of mouse cecal mucus (20,ug) (b) were hy-
drolyzed and derivatized with phenyl isothiocyanate and were
injected onto a Supelcosil LC-18 column (250 by 4.6 mm). The
column was eluted with a linear gradient of ammonium acetate-
trimethylamine as described previously (3) by using a UV detector
operated at 254 nm.
mucus preparations and have demonstrated that salmonellae
and E. coli are capable of utilizing cecal mucus total lipids,
the corresponding acidic lipid fraction, and phosphatidyl-
serine as the sole sources of carbon and nitrogen and that
they do so without an extended lag period. Moreover, in
the case of S. typhimurium, it will be of interest to deter-
mine whether the ability to utilize phosphatidylserine is
required for pathogenesis in the mouse intestine. For exam-
ple, it is possible that the ability to metabolize the phospha-
tidylserine present in intestinal epithelial cell membranes
is required for successful invasion by salmonellae of intesti-
nal epithelial cells. Interestingly, these findings may also
explain why salmonellae survive and grow in chicken eggs,
which are rich in phospholipids, including phosphatidylser-
ine.
TABLE 5. Effect of phospholipase treatment on growth of
S. typhimurium SL7312 and E. coli F-18
CFU relative to input CFUb in
Strain Phospho- the indicated substratelipasea
Dialysate Total lipids Phosphatidylserine
SL7312 None 388 162 43.3
A2 2.52 1.02 1.81
D 2.28 2.74 4.05
F-18 None 479 221 87.2
A2 39.7 10.7 4.14
D 45.5 5.51 5.86
a Samples were treated with either none or 1 U of each phospholipase for 6
h at 37°C. Untreated samples were incubated without enzymes for 6 h at 37°C
and then were dialyzed, lyophilized, resuspended, and inoculated identically
to the phospholipase-treated samples.
b Input CFU per milliliter: S. typhimurium SL7312, 4.2 x 104; E. coli F-18,
2.9 x 10. Incubation was at 37'C for 6 h.
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ADDENDUM IN PROOF
Data obtained after acceptance of this paper show that
E. coli and salmonellae can also utilize phosphatidylserine as
the sole source of phosphate for growth.
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